Kindred Healthcare, Inc. (KND) Downgraded by Zacks Investment Research

Zacks Investment Research downgraded shares of Kindred Healthcare, Inc. (NYSE:KND) from a hold rating to a sell rating in a research note published on Tuesday morning.

According to Zacks, “Kindred Healthcare, Inc. is one of the largest providers of long-term healthcare services in the United States. Their health services division provides long-term care services by operating nursing centers and a rehabilitation therapy business, and their hospital division provides long-term acute care services by operating hospitals and an institutional pharmacy business. “

Several other equities analysts have also weighed in on KND. Mizuho reissued a neutral rating and issued a $9.00 price objective on shares of Kindred Healthcare in a research report on Monday, July 3rd. BidaskClub lowered shares of Kindred Healthcare from a buy rating to a hold rating in a research report on Wednesday, July 12th. Deutsche Bank AG lowered their price target on shares of Kindred Healthcare from $13.00 to $10.00 and set a buy rating on the stock in a research report on Monday, August 7th. Royal Bank Of Canada lowered their price target on shares of Kindred Healthcare from $9.00 to $7.50 and set a sector perform rating on the stock in a research report on Thursday, September 21st. Finally, Bank of America Corporation lowered their price target on shares of Kindred Healthcare from $7.50 to $6.50 and set an underperform rating on the stock in a research report on Thursday, September 21st. Six equities research analysts have rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company’s stock. Kindred Healthcare currently has a consensus rating of Hold and a consensus target price of $8.75.

Kindred Healthcare (KND) traded down 0.407% on Tuesday, hitting $6.125. 294,485 shares of the stock traded hands. The firm’s 50 day moving average is $6.99 and its 200 day moving average is $8.99. Kindred Healthcare has a 52 week low of $5.50 and a 52 week high of $11.90. The stock’s market cap is $532.99 million.

Kindred Healthcare (NYSE:KND) last issued its quarterly earnings data on Thursday, August 3rd. The health services provider reported $0.19 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.16 by $0.03. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.59 billion. Kindred Healthcare had a negative net margin of 16.31% and a positive return on equity of 3.49%. The company’s revenue was down 4.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.38 earnings per share. Equities analysts anticipate that Kindred Healthcare will post $0.22 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This news story was posted by Stock Observer and is the property of of Stock Observer. If you are accessing this news story on another website, it was stolen and republished in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.thestockobserver.com/2017/10/13/kindred-healthcare-inc-knd-downgraded-by-zacks-investment-research.html.

A number of large investors have recently added to or reduced their stakes in KND. SG Americas Securities LLC grew its stake in Kindred Healthcare by 28.1% during the first quarter. SG Americas Securities LLC now owns 20,915 shares of the health services provider’s stock worth $175,000 after buying an additional 4,584 shares in the last quarter. JPMorgan Chase & Co. grew its stake in Kindred Healthcare by 149.4% during the second quarter. JPMorgan Chase & Co. now owns 2,104,618 shares of the health services provider’s stock worth $24,518,000 after buying an additional 1,260,753 shares in the last quarter. Bank of New York Mellon Corp grew its stake in Kindred Healthcare by 2.4% during the second quarter. Bank of New York Mellon Corp now owns 1,488,869 shares of the health services provider’s stock worth $17,345,000 after buying an additional 34,553 shares in the last quarter. Point72 Asia Hong Kong Ltd acquired a new stake in Kindred Healthcare during the first quarter worth about $121,000. Finally, Goldman Sachs Group Inc. grew its stake in Kindred Healthcare by 2.6% during the first quarter. Goldman Sachs Group Inc. now owns 866,881 shares of the health services provider’s stock worth $7,239,000 after buying an additional 22,210 shares in the last quarter. 88.14% of the stock is currently owned by institutional investors and hedge funds.

About Kindred Healthcare

Kindred Healthcare, Inc, incorporated on March 27, 1998, is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Get a free copy of the Zacks research report on Kindred Healthcare (KND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Kindred Healthcare (NYSE:KND)

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply